Work

A phase I safety, pharmacological and biological study of the farnesyl protein transferase inhibitor, tipifarnib and capecitabine in advanced solid tumors

Year: 2006

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdl282

Authors: L. Gore, S.N. Holden, R.B. Cohen, M. Morrow, A.S. Pierson, C.L. O'Bryant, M. Persky, D. Gustafson, C. Mikule, S. Zhang, P.A. Palmer, S.G. Eckhardt

Institutions: University of Colorado Cancer Center, University of Virginia, Janssen Research & Development (United States)

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Cancer Institute

Award: Paul Calabresi Award in Clinical Oncology Research

OpenAlex ID: W2168623442

FWCI: 1.56

Cites: 33

Cited by: 18

Related to: 10